Menopause Review
eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


1/2025
vol. 24
 
Share:
Share:
Original paper

Sleep traits and risk of premature ovarian insufficiency – two-sample and multivariate mendelian randomisation analysis

Lili Wei
1
,
Baoman Ma
2
,
Dan Wu
2
,
Le Wang
2
,
Xueting He
2
,
Ying Gong
2
,
Chujuan Lin
2

  1. Guangxi University of Traditional Chinese Medicine, Zhuangyi Clinical Medical College, Nanning, China
  2. Guangxi International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China
Menopause Rev 2025; 24(1): 15-24
Online publish date: 2025/05/12
Article file
- Sleep traits.pdf  [1.96 MB]
Get citation
 
PlumX metrics:
 

Introduction

The global prevalence of infertility ranges from 10 to 15%, making reproductive disorders a significant concern in global health [1, 2]. Infertility can be attributed to various aetiological factors. Premature ovarian insufficiency (POI) is the term used to describe the permanent decrease in ovarian function that happens in women before the age of 40 years. It is defined by decreased oestrogen production and increased gonadotropin levels, which lead to a number of symptoms [3]. The prevalence of POI is approximately 1–4%, but due to changes in social environment and increased life and work pressures, its prevalence is gradually rising with a trend towards younger ages [4]. Premature ovarian insufficiency is not merely a cause of ovarian hormone deficiency and infertility but is also linked to elevated health risks including cardiovascular disease, osteoporosis, and a certain degree of cognitive decline [5]. Furthermore, it has been reported that POI patients may experience a shortened life expectancy [6]. However, due to the high heterogeneity and multifactorial nature of POI, the underlying biological mechanisms for most cases remain to be further elucidated [7].
Sleep, an intrinsic biological rhythm of the human body, is essential for maintaining homeostasis, modulating neuroendocrine functions, and regulating energy metabolism. It represents not only the cyclical physiological and psychological phenomena but also serves as a critical nexus for recovery, information integration, memory consolidation, and physical rejuvenation [8]. In recent years, sleep disturbances have garnered considerable attention as a significant risk factor impacting public health. An increasing body of research indicates a strong correlation between reduced sleep duration and quality with the heightened incidence of chronic diseases and elevated all-cause mortality, encompassing conditions such as asthma, hypertension, and myocardial infarction [9, 10]. It is noteworthy that the escalating prevalence of infertility has paralleled the rise in sleep deprivation and disruption over recent decades [11]. Studies indicate that women in their reproductive years who suffer from sleep deficiency are at an elevated risk of menstrual irregularities and insulin resistance [12]. Additionally, detrimental sleep habits, characterised by shortened nocturnal sleep duration, inconsistent sleep-wake rhythms, and inadequate amounts of sleep, can adversely affect antral follicle count, maturation, and fertilisation potential [13]. Furthermore, both insufficient and excessive sleep durations have been correlated with reduced likelihood of clinical pregnancy in women [14]. Disruptions in sleep patterns are prevalent among patients with POI, with the majority experiencing diminished sleep quality and increased susceptibility to fatigue relative to age-matched healthy controls [15]. Studies have implicated work-related and familial stressors, as well as enduring adverse life events preceding the diagnosis of POI, as significant contributors to sleep-related issues that can adversely impact health [16]. Although clinical observations suggest a correlation between sleep disturbances and POI, the nature of this association remains ambiguous due to potential confounding variables and the possibility of reverse causality.
Well-conducted randomised controlled trials are frequently regarded as the gold standard for determining causation. However, they are often resource-intensive and may face implementation challenges due to ethical considerations and budgetary limitations. Mendelian randomisation (MR) offers a compelling alternative for investigating causality, utilising single nucleotide polymorphisms (SNPs) correlated with exposure variables as instrumental variables (IVs) [17]. This approach leverages the random allocation of alleles at conception and their constancy throughout life to mitigate confounding influences and preclude bias from reverse causality, thereby enhancing the reliability of causal inferences beyond those achievable by conventional observational research [18, 19]. Given its unique advantages, MR has come out as a viable technique for evaluating the connections between numerous exposures and reproductive health outcomes [20, 21]. In this study, we will employ MR analysis on genome-wide association study (GWAS) data of sleep traits and POI to elucidate the underlying genetic causality, thereby informing future preventative and therapeutic strategies.

Methods research design

As depicted in Figure 1, we conducted both two-sample and multivariate MR analysis. The two-sample MR analysis was used to look at the association among 11 sleep traits and POI. The study cohort was restricted to individuals of European descent, thereby mitigating potential biases attributable to population stratification. The multivariate MR analysis facilitated the estimation of the causal effects of multiple risk factors on POI susceptibility by integrating all relevant exposures within a single model framework.
Data sources
Identify eligible GWAS datasets for both exposure and outcome variables, encompassing resources from the UK Biobank, Neale Lab, IEU open GWAS, and FinnGen. Given that this investigation represents a secondary analysis of publicly available datasets, no further ethical approval was necessary.
Eleven sleep-related traits, encompassing sleep duration, sleep chronotype, insomnia, hypersomnia, getting up in the morning, daytime dozing, nap during day, sleep apnoea, snoring, trouble falling asleep, and sleep disorders, were extracted from GWAS datasets to serve as exposure variables. Premature ovarian insufficiency was designated as the outcome measure. In this investigation, the corresponding phenotypic code referenced was ‘finn-b-E4_OVARFAIL’. An overview of the database is presented in Table 1.
The selection of instrumental variables
To ensure the precision and robustness of the MR analysis, a stringent IV selection process was applied to the 11 sleep traits. Adhering to the 3 fundamental assumptions underlying MR, we utilised the genome-wide significance threshold for SNPs (p < 5 × 10–6) and linkage disequilibrium criteria (r2 < 0.001, 10000 kb) to ascertain the independence and relevance of the SNPs. Additionally, we employed F-statistics to assess the efficacy of the IVs, excluding those with F-statistics below 10 to mitigate the potential bias associated with weak instruments [22, 23].
Mendelian randomisation analysis
In the two-sample MR analysis, we employed the inverse variance weighted (IVW) method as the primary analytical approach. The inverse variance weighted method is widely recognised as the gold standard for evaluating causality [24]. To bolster our analysis, we additionally incorporated the MR-Egger, weighted median, simple median, and weighted mode methods. The MR-Egger method ascertains the causal effect by leveraging the slope coefficient derived from Egger regression, offering a more robust causal estimation, even in scenarios where some IVs may not be valid. The weighted median method can potentially exclude up to 50% of non-informative IVs, thereby enhancing the precision of thte analysis. The weighted mode method approach necessitates the identification of multiple variables to serve as an effective instrument for detecting the same causal effect. The simple median method categorises SNPs with analogous values into clusters and employs the cluster with the highest frequency of SNPs to assess causal relationships [25–27].
Building upon the two-sample MR analysis, the multivariate MR approach enables the estimation of the causal effects of multiple risk factors on the risk of POI by integrating all relevant exposures within a unified model framework [28]. We combined the significant exposure factors in the two-sample MR analysis. After excluding repeated SNPs, we obtained the effect of each SNP and the corresponding standard error from the exposure and results. In multivariate MR analysis, both IVW and MR-Egger methods based on weighted linear regression are used to infer causality.
Sensitivity analysis
Cochran’s Q statistical analysis was conducted to assess heterogeneity among the studies. The resulting p-value from Cochran’s Q test exceeded 0.05, indicating that there was no significant heterogeneity [29]. The MR-Egger intercept was employed to scrutinizse the potential pleiotropic effects. A p-value greater than 0.05 indicated no evidence of pleiotropy [30]. The leave-one-out method was employed for conducting sensitivity analyses, wherein the MR effect estimation was iteratively recalculated. By sequentially excluding a single genetic variant per iteration, the analysis assessed the individual contribution of each variant to the composite estimation, identified potential outliers, and affirmed the robustness of the aggregate effect [31]. The funnel plot was used to detect result bias.
Statistical analysis
All Mendelian randomisation analyses were conducted utilising R software, version 4.4.1. The R packages used included ‘MRInstruments’, ‘MRPRESSO’, ‘TwoSampleMR’, ‘MVMR’, and ‘MendelianRandomization’. Statistical significance was defined as a p-value of less than 0.05 for all analyses.

Result

Two-sample Mendelian randomisation analysis
This study encompassed 11 sleep-related traits as exposures, with each IV exhibiting an F-statistic exceeding the threshold of 10. As delineated in Figure 2 a positive correlation was observed between sleep duration and POI, whereas an inverse relationship was noted between sleep chronotype and POI. In the association study between sleep duration and POI, 8 palindrome SNPs (rs11043328, rs12670234, rs17732997, rs2186122, rs2249966, rs269054, rs7943526, rs8015629) were excluded before MR analysis, and 215 SNPs were finally included. The inverse variance weighted method found a positive connection between sleep duration and POI ( = 1.464, OR = 4.323, 95% CI: 1.093–17.112, p = 0.037), showing that longer sleep duration reduced the risk of POI.
In the association study between sleep chronotype and POI, 14 palindrome SNPs (rs1000665, rs1348990, rs1837446, rs2304467, rs3796618, rs4533855, rs4595586, rs4729854, rs4784655, rs7210415, rs7586062, rs812925, rs848552, rs9962650) were excluded before MR analysis. Finally, 316 SNPs were included. The inverse variance weighted method found a negative connection between sleep chronotype and POI ( = –0.915, OR = 0.400, 95% CI: 0.173–0.925, p = 0.032 ), suggesting that preferring morning sleep may lower the incidence of POI. Figure 3 shows the scatter plot of the MR analysis of 2 sleep traits.
Sensitivity analysis
Cochran’s Q test results indicated no significant heterogeneity within the MR analysis outcomes for sleep duration and sleep chronotype. The p-values derived from the MR-Egger regression intercepts consistently exceeded 0.05, suggesting the absence of horizontal pleiotropy (Table 2). The leave-one-out method demonstrated that the exclusion of individual SNPs did not substantially influence the estimation of causal relationships, thereby confirming the robustness of the MR analysis findings (Fig. 4). Additionally, the funnel plot depicting the distribution of causal effects exhibited fundamental symmetry, with no evident signs of bias (Fig. 5).
Multivariate Mendelian randomisation analysis
Two POI-related sleep traits were selected for multivariate MR analysis to correct the effects of multiple sleep traits on the outcome. The results showed that when sleep duration (OR = 0.362, 95% CI: 0.038–3.385, p = 0.373) and sleep chronotype (OR = 0.502, 95% CI: 0.168–1.495, p = 0.216) were activated at the same time, there was no common effect on POI.

Discussion

Leveraging an extensive array of openly accessible genetic datasets, we delineated the causal nexus between 11 sleep-related traits and POI. To our knowledge, this is the first MR analysis to investigate the causal relationship between a range of sleep traits and POI. Our findings from the two-sample MR analysis indicate a significant causal nexus between sleep duration and chronotype with POI. Conversely, the multivariate MR analysis did not discern a concerted effect of these sleep traits on POI.
Research has indicated that women with POI typically exhibit poorer sleep quality, extended sleep durations, and elevated fatigue indices relative to their counterparts with normal ovarian function [32]. Moreover, the prevalence of inadequate sleep duration and sleep disturbances is higher in infertile women compared to fertile women, with a significant increase in infertility risk observed in women whose sleep duration is confined to ≤ 7 hours [33]. The aforementioned findings align with our MR analysis, substantiating the observed relationship between sleep duration with POI. Drawing from the clinical profiles and MR-derived insights of POI patients, we postulate that inadequate sleep duration could be a risk factor for POI, with sufficient sleep potentially mitigating disease risk. The interplay between circadian rhythms and sleep homeostasis is crucial for modulating sleep duration and associated physiological mechanisms. Chronic sleep deficiency and deprivation are implicated in the disruption of circadian rhythms [34, 35]. Physiologically, folliculogenesis exhibits distinct circadian patterns, synchronised with photoperiod and endocrine cues [36, 37]. Key regulators of female reproductive function, such as sex steroid hormones, gonadotropins, and sex hormone-binding globulin (SHBG), are subject to the influence of endogenous circadian rhythms, with a potentially heightened influence during the follicular phase [38, 39]. Circadian clock genes, notably BMAL1, are pivotal in modulating reproductive functions. The rhythmic expression of BMAL1 in ovarian granulosa and theca cells significantly impacts the synthesis of ovarian steroid hormones and the ovulatory process. Conditional deletion or aberrant transcription of the BMAL1 gene in theca cells alters the mRNA expression pattern of the pituitary luteinising hormone (LH) receptor, leading to reduced ovarian sensitivity to LH and compromised ovulation efficacy [40, 41].
Furthermore, the activation of primordial follicles during the female reproductive cycle is constrained, and disruptions to this process can precipitate aberrant follicular development. Excessive primordial follicle activation may diminish the ovarian reserve pool [42]. Premature ovarian insufficiency often arises from an early depletion of the follicular reserve and heightened follicular atresia, culminating in impaired oocyte and follicular development alongside ovarian dysfunction. Sleep deprivation may deplete follicular reserves, potentially by accelerating the activation and atresia of primordial follicles [43]. The study also highlighted that sleep insufficiency can induce alterations in the gut microbiota of adolescent women, potentially impacting the systemic metabolism of the nicotinamide adenine dinucleotide (NAD+) pathway, thereby compromising the mitochondrial energy metabolism in ovarian oocytes and leading to reduced POI and oocyte meiotic competence [43].
Our MR analysis found a substantial negative causal link between sleep chronotype and the probability of POI, suggesting that individuals with a propensity for early morning sleep patterns may lower their risk of POI. Analogous to various biological processes, sleep patterns are intricately linked to immune responses, inflammatory processes, and fluctuations in circulating immune cell counts [44]. Cytokines such as interleukin-1, interleukin-6 (IL-6), and tumour necrosis factor- (TNF-) play pivotal roles in chronic inflammation. Zhai et al. [45] reported elevated levels of these inflammatory markers in young individuals with late sleep chronotypes. Furthermore, Ma et al. [46] highlighted that during pregnancy, sleep insufficiency, particularly late sleep onset and snoring, may exacerbate systemic chronic inflammation. Chronic inflammation, a pervasive condition over the long term, can result in sustained elevated levels of inflammatory mediators, including IL-6 and TNF-, potentially leading to irreversible pathological alterations within the ovarian tissue of females [47]. In POI patients, the engulfment of senescent cells via phagocytosis and the extensive apoptosis of ovarian macrophages are frequently observed phenomena, accompanied by an upregulation of pro-inflammatory cytokines and a downregulation of anti-inflammatory cytokines, as seen in POI animal models [48, 49]. Furthermore, chronic inflammation may disrupt the homeostatic mechanisms of the hypothalamic-pituitary-ovarian axis, precipitating hormonal imbalances that can adversely impact ovarian function [50].
In addition, sleep chronotype is likely to influence the secretion of sex hormones. Ren et al. [51] demonstrated that sleep chronotype significantly impacts not only the secretion of female testosterone but also exhibits a substantial causal link with oestrogen secretion, with early morning sleep patterns being more favourable for oestrogen production. Similarly, Peplonska et al. [52] reported an inverse correlation between the frequency of night shifts among premenopausal nurses and circulating oestrogen levels. Given that a primary characteristic of POI is the erratic decline in oestrogen levels [53], it is plausible to posit that sleep chronotype may indirectly contribute to the pathogenesis of POI through the modulation of oestrogen levels.
Additionally, we employed a multivariate MR analysis, which demonstrated no detectable shared causal influence of the 2 sleep traits on the probability of POI. This investigation utilised a diverse array of MR methodologies to furnish compelling evidence supporting the causal nexus among sleep traits with POI risk. However, it is important to recognise the study’s shortcomings: the absence of individual-level data precludes a more granular stratified analysis, thereby constraining an in-depth exploration of the impact of sleep traits on discrete populations. The research’s primary reliance on a European population database may also restrict the generalisability of the findings across diverse ethnicities. Ultimately, to enhance the comprehensive assessment of the correlation between sleep traits and POI, a more lenient threshold was applied in our analysis, which could potentially elevate the likelihood of false-positive outcomes.

Conclusions

We discerned a positive correlation between sleep duration and the risk of POI, while an inverse relationship was observed with sleep chronotype. However, no shared causal influence of these sleep traits on POI risk was identified. Subsequent research endeavours should explore the potential of enhancing sleep patterns through behavioural interventions and pharmacological treatments to mitigate the risk of POI. The development of these preventive and therapeutic strategies merits further investigation within clinical settings.

Disclosures

  1. This study was supported by the Guangxi Natural Science Foundation Youth Fund (2024GXNSFBA010163), Guangxi University of Traditional Chinese Medicine School-level Scientific Research Project Youth Fund (2023QN018), and the Guangxi Graduate Education Innovation Program Project (YCBXJ2022006).
  2. Assistance with the article: None.
  3. Financial support and sponsorship: None.
  4. Conflicts of interest: None.
References
1. Chen S, Sun S, Cai M, et al. A metabolome-wide Mendelian randomization study prioritizes causal circulating metabolites for reproductive disorders including primary ovarian insufficiency, polycystic ovary syndrome, and abnormal spermatozoa. J Ovarian Res 2024; 17: 166.
2. Dai M, Guo W, Zhu S, et al. Type 2 diabetes mellitus and the risk of abnormal spermatozoa: A Mendelian randomization study. Front Endocrinol (Lausanne) 2022; 13: 1035338.
3. Brent S, Christakis M, Shirreff L. Primary ovarian insufficiency. CMAJ 2023; 195: E956.
4. Golezar S, Ramezani Tehrani F, Khazaei S, Ebadi A, Keshavarz Z. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric 2019; 22: 403-411.
5. Ishizuka B. Current understanding of the etiology, symptomatology, and treatment options in premature ovarian insufficiency (POI). Front Endocrinol (Lausanne) 2021; 12: 626924.
6. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010; 65: 161-166.
7. Verrilli L. Primary ovarian insufficiency and ovarian aging. Obstet Gynecol Clin North Am 2023; 50: 653-661.
8. Baranwal N, Yu PK, Siegel NS. Sleep physiology, pathophysiology, and sleep hygiene. Prog Cardiovasc Dis 2023; 77: 59-69.
9. Boivin DB, Boudreau P, Kosmadopoulos A. Disturbance of the circadian system in shift work and its health impact. J Biol Rhythms 2022; 37: 3-28.
10. Tabara Y, Matsumoto T, Murase K, et al. Sleep-related factors associated with masked hypertension: the Nagahama study. J Hypertens 2023; 41: 1298-1305.
11. Lateef OM, Akintubosun MO. Sleep and reproductive health. J Circadian Rhythms 2020; 18: 1.
12. Lim AJ, Huang Z, Chua SE, Kramer MS, Yong EL. Sleep duration, exercise, shift work and polycystic ovarian syndrome-related outcomes in a healthy population: a cross-sectional study. PLoS One 2016; 11: e0167048.
13. Yao QY, Yuan XQ, Liu C, et al. Associations of sleep characteristics with outcomes of IVF/ICSI treatment: a prospective cohort study. Hum Reprod 2022; 37: 1297-1310.
14. Willis SK, Hatch EE, Wesselink AK, Rothman KJ, Mikkelsen EM, Wise LA. Female sleep patterns, shift work, and fecundability in a North American preconception cohort study. Fertil Steril 2019; 111: 1201-1210 e1201.
15. Ates S, Aydin S, Ozcan P, Bakar RZ, Cetin C. Sleep, depression, anxiety and fatigue in women with premature ovarian insufficiency. J Psychosom Obstet Gynaecol 2022; 43: 482-487.
16. Sun J, Fan Y, Guo Y, et al. Chronic and cumulative adverse life events in women with primary ovarian insufficiency: an exploratory qualitative study. Front Endocrinol (Lausanne) 2022; 13: 856044.
17. Nazarzadeh M, Pinho-Gomes AC, Bidel Z, et al. Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study. Eur Heart J 2020; 41: 3913-3920.
18. Clayton GL, Gonçalves A, Soares, et al. A framework for assessing selection and misclassification bias in mendelian randomisation studies: an illustrative example between body mass index and covid-19. BMJ 2023; 381: e072148.
19. Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ 2021; 375: n2233.
20. Sun S, Jiao M, Han C, et al. Causal effects of genetically determined metabolites on risk of polycystic ovary syndrome: a Mendelian randomization study. Front Endocrinol (Lausanne) 2020; 11: 621.
21. Yang Q, Borges MC, Sanderson E, et al. Associations between insomnia and pregnancy and perinatal outcomes: evidence from mendelian randomization and multivariable regression analyses. PLoS Med 2022; 19: e1004090.
22. Burgess S, Cronjé HT. Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principles. eGastroenterology 2024; 2: e100042.
23. Kim MS, Song M, Shin JI, Won HH. How to interpret studies using Mendelian randomisation. BMJ Evid Based Med 2023; 28: 251-254.
24. Burgess S, Davey Smith G, Davies NM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res 2019; 4: 186.
25. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015; 44: 512-525.
26. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016; 40: 304-314.
27. Dobrijevic E, van Zwieten A, Kiryluk K, Grant AJ, Wong G, Teixeira-Pinto A. Mendelian randomization for nephrologists. Kidney Int 2023; 104: 1113-1123.
28. Ni J, Zhou W, Cen H, et al. Evidence for causal effects of sleep disturbances on risk for osteoarthritis: a univariable and multivariable Mendelian randomization study. Osteoarthritis Cartilage 2022; 30: 443-450.
29. Mazidi M, Shekoohi N, Katsiki N, Banach M. Impact of lifetime concentration of mannose on renal function: insights from Mendelian randomization. Eur Heart J 2022; 43: ehac544. 2612.
30. Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 2017; 32: 377-389.
31. Zhou F, Li S, Xu H. Insomnia, sleep duration, and risk of anxiety: a two-sample Mendelian randomization study. J Psychiatr Res 2022; 155: 219-225.
32. Benetti-Pinto CL, Menezes C, Yela DA, Cardoso TM. Sleep quality and fatigue in women with premature ovarian insufficiency receiving hormone therapy: a comparative study. Menopause 2019; 26: 1141-1145.
33. Wang Z, Lai YH, Huang SY, Liu YD, Chen SL. Combined impact of sleep and obesity on female infertility in the NHANES 2017-2020. BMC Womens Health 2024; 24: 315.
34. Lane JM, Qian J, Mignot E, Redline S, Scheer F, Saxena R. Genetics of circadian rhythms and sleep in human health and disease. Nat Rev Genet 2023; 24: 4-20.
35. McHill AW, Hull JT, Klerman EB. Chronic circadian disruption and sleep restriction influence subjective hunger, appetite, and food preference. Nutrients 2022; 14: 1800.
36. Chen M, Xu Y, Miao B, et al. Expression pattern of circadian genes and steroidogenesis-related genes after testosterone stimulation in the human ovary. J Ovarian Res 2016; 9: 56.
37. Wang F, Xie N, Wu Y, et al Association between circadian rhythm disruption and polycystic ovary syndrome. Fertil Steril 2021; 115: 771-781.
38. Lok R, Qian J, Chellappa SL. Sex differences in sleep, circadian rhythms, and metabolism: Implications for precision medicine. Sleep Med Rev 2024; 75: 101926.
39. Wang W, Hao Z, Wu Z, Cui J, Liu H. Long-term artificial/natural daytime light affects mood, melatonin, corticosterone, and gut microbiota in rats. Appl Microbiol Biotechnol 2023; 107: 2689-2705.
40. Mereness AL, Murphy ZC, Forrestel AC, et al. Conditional deletion of Bmal1 in ovarian theca cells disrupts ovulation in female mice. Endocrinology 2016; 157: 913-927.
41. Wang Y, Chen M, Xu J, et al. Core clock gene Bmal1 deprivation impairs steroidogenesis in mice luteinized follicle cells. Reproduction 2020; 160: 955-967.
42. Chon SJ, Umair Z, Yoon MS. Premature ovarian insufficiency: past, present, and future. Front Cell Dev Biol 2021; 9: 672890.
43. Yan J, Zhang X, Zhu K, et al. Sleep deprivation causes gut dysbiosis impacting on systemic metabolomics leading to premature ovarian insufficiency in adolescent mice. Theranostics 2024; 14: 3760-3776.
44. Choshen-Hillel S, Ishqer A, Mahameed F, et al. Acute and chronic sleep deprivation in residents: cognition and stress biomarkers. Med Educ 2021; 55: 174-184.
45. Zhai S, Tao S, Wu X, et al. Associations of sleep insufficiency and chronotype with inflammatory cytokines in college students. Nat Sci Sleep 2021; 13: 1675-1685.
46. Ma S, Li P, Li D, et al. Increasing systemic chronic inflammation mediated the association between poor sleep during pregnancy and gestational cardiovascular health. Sleep Health 2023; 9: 460-466.
47. Spears N, Lopes F, Stefansdottir A, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update 2019; 25: 673-693.
48. Akdemir Y, Akpolat M, Elmas O, et al Capsaicin prevents radiotherapy-induced premature ovarian failure in rats. Reprod Fertil Dev 2022; 34: 350-361.
49. Ugai T, Sasamoto N, Lee HY, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol 2022; 19: 656-673.
50. Lliberos C, Liew SH, Zareie P, La Gruta NL, Mansell A, Hutt K. Evaluation of inflammation and follicle depletion during ovarian ageing in mice. Sci Rep 2021; 11: 278.
51. Ren Z, Long J, Deng W, et al. Causal relationship between sleep traits and hypothalamic-pituitary-target gland axis function: a Mendelian randomization study. Nat Sci Sleep 2024; 16: 155-175.
52. Peplonska B, Bukowska A, Lie JA, Gromadzinska J, Zienolddiny S. Night shift work and other determinants of estradiol, testosterone, and dehydroepiandrosterone sulfate among middle-aged nurses and midwives. Scand J Work Environ Health 2016; 42: 435-446.
53. Armeni E, Paschou SA, Goulis DG, Lambrinoudaki I. Hormone therapy regimens for managing the menopause and premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab 2021; 35: 101561.
Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.